Efficacy of dimethyl fumarate in Japanese MS patient in phase 3 apex study and the open label extension study: 72 weeks interim analysis

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2019
This article has no abstract
Epistemonikos ID: 92c4f048f27142d08aced34cfb78af64c7d0c34c
First added on: Apr 29, 2026